DXRX.L Stock - Diaceutics PLC
Unlock GoAI Insights for DXRX.L
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $32.16M | $23.70M | $19.50M | $13.94M | $12.70M |
| Gross Profit | $28.27M | $19.71M | $14.04M | $10.57M | $9.33M |
| Gross Margin | 87.9% | 83.2% | 72.0% | 75.8% | 73.5% |
| Operating Income | $-2,455,000 | $-3,018,000 | $575,000 | $550,000 | $-610,000 |
| Net Income | $-1,703,000 | $-1,746,000 | $724,000 | $561,000 | $263,000 |
| Net Margin | -5.3% | -7.4% | 3.7% | 4.0% | 2.1% |
| EPS | $-0.02 | $-0.02 | $0.01 | $0.01 | $0.00 |
Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics. The company also provides DXRX patient journey that enables pharma customers to complete a longitudinal analysis of biomarker testing journeys of individual patients, which identifies opportunities for earlier testing and treatment; DXRX lab benchmarking that enables laboratories to gain competitive edge and compare key criteria to others in the industry providing metrics, such as disease, testing and methodology, market share, turnaround time, and laboratory leadership in these areas; DXRX test reimbursement, which enables pharma customers to engage with laboratories to fund the introduction of novel companion diagnostics, as well as reducing the lag time in test adoption; and DXRX test signal that delivers a real-time alert of a testing event, which allows pharma customers to identify therapeutically actionable patients in the previous weeks. In addition, it offers diagnostic landscape, planning, implementation, and tracking services; and consulting services for precision medicine diagnostics. Further, the company provides test standardization, test quality assessment, test report optimization, laboratory tech support, test access and reimbursement, laboratory training, and educational resources services. Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.
Visit WebsiteEarnings History & Surprises
DXRX.LEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 11, 2026 | — | — | — | — |
Q2 2025 | Jun 30, 2025 | $-0.03 | $-0.03 | -3.3% | ✗ MISS |
Q2 2025 | May 13, 2025 | $0.02 | $0.01 | -50.9% | ✗ MISS |
Q3 2024 | Sep 17, 2024 | $-0.04 | $-0.03 | +19.5% | ✓ BEAT |
Q2 2024 | May 21, 2024 | $0.00 | $-0.00 | -186.1% | ✗ MISS |
Q3 2023 | Sep 26, 2023 | — | $-0.02 | — | — |
Q2 2023 | Apr 18, 2023 | $0.01 | $0.02 | +25.2% | ✓ BEAT |
Q2 2022 | Jun 30, 2022 | — | $-0.01 | — | — |
Q4 2021 | Dec 31, 2021 | $0.01 | $0.01 | -19.2% | ✗ MISS |
Q2 2021 | Jun 30, 2021 | — | $-0.00 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.01 | — | — |
Q2 2020 | Jun 30, 2020 | — | $0.02 | — | — |
Q4 2019 | Dec 31, 2019 | — | $0.03 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.03 | — | — |
Q4 2018 | Dec 31, 2018 | — | $0.04 | — | — |
Q2 2018 | Jun 30, 2018 | — | $-0.01 | — | — |
Q1 2018 | Jan 31, 2018 | — | $0.00 | — | — |
Q2 2017 | Jun 30, 2017 | — | $0.00 | — | — |
Q1 2017 | Jan 31, 2017 | — | $0.00 | — | — |
Q2 2016 | Jun 30, 2016 | — | $0.01 | — | — |
Latest News
Frequently Asked Questions about DXRX.L
What is DXRX.L's current stock price?
What is the analyst price target for DXRX.L?
What sector is Diaceutics PLC in?
What is DXRX.L's market cap?
Does DXRX.L pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to DXRX.L for comparison